AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
3 STEP HIGH-DOSE CHEMOTHERAPY IN POOR-PROGNOSIS NON-HODGKIN-LYMPHOMA
Authors: BALLESTRERO A CLAVIO M FERRANDO F SECONDO V BASTA P GONELLA R GARUTI A MIGLINO M PIERRI I CANEPA L BELTRAMI G VALLEBELLA E GHIO R GOBBI M PATRONE F
Citation: A. Ballestrero et al., 3 STEP HIGH-DOSE CHEMOTHERAPY IN POOR-PROGNOSIS NON-HODGKIN-LYMPHOMA, Bone marrow transplantation, 21, 1998, pp. 613-613
HIGH-DOSE THERAPY WITH PBPC IN MM - A PRELIMINARY-REPORT OF GENOA EXPERIENCE
Authors: FERRANDO F CLAVIO M BALLESTRERO A BALLERINI F CAVALIERE M BASTA P GONELLA R GARUTI A MIGLINO M PIERRI I BELTRAMI G GHIO R GOBBI M PATRONE F
Citation: F. Ferrando et al., HIGH-DOSE THERAPY WITH PBPC IN MM - A PRELIMINARY-REPORT OF GENOA EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 739-739
EXPANSION OF PURIFIED CIRCULATING CD34-DOSE CHEMOTHERAPY( HEMATOPOIETIC PROGENITOR CELLS (HPC) AS POSSIBLE SUPPORT FOR HIGH)
Authors: BALLEARI E BALLESTRERO A BASON C BASTA P FERRANDO F GARRE S GARUTI A MASSA G RICHERO P PATRONE F GHIO R
Citation: E. Balleari et al., EXPANSION OF PURIFIED CIRCULATING CD34-DOSE CHEMOTHERAPY( HEMATOPOIETIC PROGENITOR CELLS (HPC) AS POSSIBLE SUPPORT FOR HIGH), Bone marrow transplantation, 21, 1998, pp. 829-829
COMPLEX STRUCTURAL INVOLVEMENT OF CHROMOSOME-7 IN PRIMARY MYELODYSPLASTIC SYNDROMES DETERMINED BY FLUORESCENCE IN-SITU HYBRIDIZATION
Authors: SESSAREGO M FUGAZZA G GOBBI M BRUZZONE R BISIO R GHIO R PATRONE F
Citation: M. Sessarego et al., COMPLEX STRUCTURAL INVOLVEMENT OF CHROMOSOME-7 IN PRIMARY MYELODYSPLASTIC SYNDROMES DETERMINED BY FLUORESCENCE IN-SITU HYBRIDIZATION, Cancer genetics and cytogenetics, 106(2), 1998, pp. 110-115
FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CERRI R PIERRI I BALLEARI E GATTO S BELTRAMI G MASOUDI B CAVALIERE M RISSO M PIETRASANTA D QUINTINO S DAMASIO E GHIO R GOBBI M
Citation: M. Clavio et al., FLUDARABINE, ARA-C AND ANTRACYCLINE - A SHORT, INTENSIVE AND TOLERABLE INDUCTION THERAPY OF DE-NOVO ACUTE MYELOID-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 220-221
FLUDARABINE COMBINATIONS WITH ARA-C AND ANTRACYCLINE AS FIRST-LINE INDUCTION THERAPY OF SECONDARY AML
Authors: PIERRI I CLAVIO M GATTO S CERRI R CANEPA L GATTI AM BALLERINI F QUINTINO S MASOUDI B CAVALIERE M SPRIANO R GHIO R DAMASIO E GOBBI H
Citation: I. Pierri et al., FLUDARABINE COMBINATIONS WITH ARA-C AND ANTRACYCLINE AS FIRST-LINE INDUCTION THERAPY OF SECONDARY AML, British Journal of Haematology, 102(1), 1998, pp. 221-221
INCREASED BRONCHOALVEOLAR GRANULOCYTES AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR DURING EXACERBATIONS OF CHRONIC-BRONCHITIS/
Authors: BALBI B BASON C BALLEARI E FIASELLA F PESCI A GHIO R FABIANO F
Citation: B. Balbi et al., INCREASED BRONCHOALVEOLAR GRANULOCYTES AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR DURING EXACERBATIONS OF CHRONIC-BRONCHITIS/, The European respiratory journal, 10(4), 1997, pp. 846-850
INTRAVENOUS IRON IS EFFECTIVE IN TREATING THE ANEMIA OF RHEUMATOID-ARTHRITIS AND IS NOT ASSOCIATED WITH FLARES OF SYNOVITIS
Authors: CIMMINO MA PARISI M QUERCI G GHIO R ACCARDO S
Citation: Ma. Cimmino et al., INTRAVENOUS IRON IS EFFECTIVE IN TREATING THE ANEMIA OF RHEUMATOID-ARTHRITIS AND IS NOT ASSOCIATED WITH FLARES OF SYNOVITIS, Clinical rheumatology, 16(2), 1997, pp. 215-216
COMBINED-MODALITY TREATMENT WITH A WEEKLY BRIEF CHEMOTHERAPY (ACOP-B)FOLLOWED BY LOCOREGIONAL RADIOTHERAPY IN LOCALIZED-STAGE INTERMEDIATE-GRADE TO HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: FREILONE R BOTTO B VITOLO U BERTINI M AUDISIO E CALVI R CUCCHI M DECRESCENZO A GALLAMINI A GHIO R GRISO L LEVIS A MASSARA G ORSUCCI L RICARDI U SCALABRINI DR SALVI F SECONDO V RESEGOTTI L
Citation: R. Freilone et al., COMBINED-MODALITY TREATMENT WITH A WEEKLY BRIEF CHEMOTHERAPY (ACOP-B)FOLLOWED BY LOCOREGIONAL RADIOTHERAPY IN LOCALIZED-STAGE INTERMEDIATE-GRADE TO HIGH-GRADE NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(9), 1996, pp. 919-924
HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA
Authors: CLAVIO M CARRARA P MIGLINO M PIERRI I CANEPA L BALLEARI E GATTI AM CERRI R CELESTI L VALLEBELLA E SESSAREGO M PATRONE F GHIO R DAMASIO E GOBBI M
Citation: M. Clavio et al., HIGH EFFICACY OF FLUDARABINE-CONTAINING THERAPY (FLAG-FLANG) IN POOR-RISK ACUTE MYELOID-LEUKEMIA, Haematologica, 81(6), 1996, pp. 513-520
MULTIPLE-MYELOMA IN THE ELDERLY - CLINICAL-FEATURES AND RESPONSE TO TREATMENT IN 113 PATIENTS
Authors: CLAVIO M CASCIARO S GATTI AM SPRIANO M BONANNI F POGGI A VALLEBELLA E PIETRASANTA D PRENCIPE E GORETTI R VIMERCATI R ROSSI E MASOUDI B GHIO R BOCCACCIO P RICCIARI S DAMASIO E GOBBI M
Citation: M. Clavio et al., MULTIPLE-MYELOMA IN THE ELDERLY - CLINICAL-FEATURES AND RESPONSE TO TREATMENT IN 113 PATIENTS, Haematologica, 81(3), 1996, pp. 238-244
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR LONG-TERM TREATMENT OF ANEMIA INPAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: BALLEARI E GATTI AM MARENI C MASSA G MARMONT AM GHIO R
Citation: E. Balleari et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR LONG-TERM TREATMENT OF ANEMIA INPAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, Haematologica, 81(2), 1996, pp. 143-147
AUTOGRAFTING WITH PHILADELPHIA (PH) CHROMOSOME-NEGATIVE OR PARTIALLY NEGATIVE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
Authors: PRENCIPE E LERMA E BENVENUTO F PODESTA M PITTO A VASSALLO F SORACCO M FRASSONI F GATTI AM GHIO R CARELLA AM
Citation: E. Prencipe et al., AUTOGRAFTING WITH PHILADELPHIA (PH) CHROMOSOME-NEGATIVE OR PARTIALLY NEGATIVE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, Experimental hematology, 24(9), 1996, pp. 94-94
FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS
Authors: GOBBI M CLAVIO M MIGLINO M CARRARA P BALLEARI E CERRI R PIERRI I CANEPA L CELESTI L VALLEBELLA E CAVALIERE M PIETRASANTA D GENNARO M GHIO R DAMASIO E
Citation: M. Gobbi et al., FLUDARABINE, ARA-C, G-CSF WITH OR WITHOUT MITOXANTRONE (FLANG-FLAG) ARE TOLERABLE AND EFFECTIVE IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA PATIENTS, Experimental hematology, 24(9), 1996, pp. 585-585
IN-VIVO EFFECTS OF 5 DIFFERENT FRACTIONS OF THYMUSTIMULIN ON HEMATOPOIETIC RECOVERY OF MICE TREATED WITH CYCLOPHOSPHAMIDE
Authors: BALLEARI E BASON C GOTTA F MASSA G BATTAGLIA A GHIO R
Citation: E. Balleari et al., IN-VIVO EFFECTS OF 5 DIFFERENT FRACTIONS OF THYMUSTIMULIN ON HEMATOPOIETIC RECOVERY OF MICE TREATED WITH CYCLOPHOSPHAMIDE, International journal of immunotherapy, 12(3-4), 1996, pp. 53-62
THERAPY WITH RECOMBINANT ERYTHROPOIETIN IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: BALLEARI E MARENI C MARMONT AM GHIO R
Citation: E. Balleari et al., THERAPY WITH RECOMBINANT ERYTHROPOIETIN IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, British Journal of Haematology, 94(2), 1996, pp. 424-424
SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA
Authors: GOBBI M CLAVIO M PIERRI I CANEPA L MIGLINO M CELESTI L CARRARA P GATTI AM VALLEBELLA E PIETRASANTA D CAVALIERE M DAMASIO E GHIO R
Citation: M. Gobbi et al., SHORT, INTENSIVE FLUDARABINE CONTAINING INDUCTION THERAPY (FLAG-FLANG) IN BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 863-863
ALTERED PRODUCTION OF CYTOKINES MODULATING HEMATOPOIESIS BY CULTURED T-LYMPHOCYTES OF SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION
Authors: BALLEARI E TIMITILLI S BASON C PUPPO F MASSA G BRENCI S INDIVERI F GHIO R
Citation: E. Balleari et al., ALTERED PRODUCTION OF CYTOKINES MODULATING HEMATOPOIESIS BY CULTURED T-LYMPHOCYTES OF SUBJECTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION, FCI. Fundamental and clinical immunology, 3(3), 1995, pp. 123-129
CYTOGENETIC CLONALITY IN CHRONIC MYELOMONOCYTIC LEUKEMIA STUDIED WITHFLUORESCENCE IN-SITU HYBRIDIZATION
Authors: FUGAZZA G BRUZZONE R DEJANA AM GOBBI M GHIO R PATRONE F RATTENNI S SESSAREGO M
Citation: G. Fugazza et al., CYTOGENETIC CLONALITY IN CHRONIC MYELOMONOCYTIC LEUKEMIA STUDIED WITHFLUORESCENCE IN-SITU HYBRIDIZATION, Leukemia, 9(1), 1995, pp. 109-114
4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH DOUBLE HEMATOPOIETIC PROGENITOR-CELL RESCUE FOR METASTATIC BREAST-CANCER
Authors: PATRONE F BALLESTRERO A FERRANDO F BREMA F MORAGLIO L VALBONESI M BASTA P GHIO R GOBBI M SESSAREGO M
Citation: F. Patrone et al., 4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH DOUBLE HEMATOPOIETIC PROGENITOR-CELL RESCUE FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(4), 1995, pp. 840-846
FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS
Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS
Authors: CLAVIO M CARRARA P SPRIANO M PIERRI I CANEPA L MIGLINO M CELESTI L ROSSI E GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Clavio et al., FLUDARABINE THERAPY IN IMMUNOCYTOMA AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS, Journal of experimental & clinical cancer research, 13(3), 1994, pp. 257-263
FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY
Authors: SPRIANO M CLAVIO M CARRARA P CANEPA L MIGLINO M PIERRI I CELESTI L ROSSI E VIMERCATI R BRUNI R SANTINI G GATTI AM STURA P GHIO R PATRONE F DAMASIO E GOBBI M
Citation: M. Spriano et al., FLUDARABINE IN UNTREATED AND PREVIOUSLY TREATED B-CLL PATIENTS - A REPORT ON EFFICIENCY AND TOXICITY, Haematologica, 79(3), 1994, pp. 218-224
SERUM LEVELS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN TREATED PATIENTS WITH CHRONICMYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: BALLEARI E BASON C VISANI G GOBBI M OTTAVIANI E GHIO R
Citation: E. Balleari et al., SERUM LEVELS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN TREATED PATIENTS WITH CHRONICMYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Haematologica, 79(1), 1994, pp. 7-12
RELEASE OF PERIPHERAL-BLOOD PROGENITOR CELLS DURING STANDARD-DOSE CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, 5-FLUOROURACIL REGIMEN PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR FOR BREAST-CANCER THERAPY
Authors: VENTURINI M DELMASTRO L MELIOLI G BALLEARI E GARRONE O PASQUETTI W BASON C GHIO R BRUZZI P ROSSO R
Citation: M. Venturini et al., RELEASE OF PERIPHERAL-BLOOD PROGENITOR CELLS DURING STANDARD-DOSE CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, 5-FLUOROURACIL REGIMEN PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR FOR BREAST-CANCER THERAPY, Cancer, 74(8), 1994, pp. 2300-2306
Risultati: 1-25 | 26-27